A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
Clinical trial NCT01276353 · COMPLETED
Trial details
- NCT number
- NCT01276353
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.